Trial Profile
A randomised phase II study of Dexamethasone (DexNP) versus Triamcinolone-acetonide in Japanese patients with diabetic macular oedema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Sep 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 02 Sep 2016 New trial record